Key Takeaways:
Corteva reported Q2 operating EPS of $2.30, beating consensus by 2.7%, while revenue of $6.38 billion missed estimates by 3.7%.
JPMorgan raised its price target on Corteva to $83 while maintaining a Neutral rating on the shares, according to an Aug. 3 note. The stock fell 11.9% after the July 30 earnings release as the revenue miss and weaker near-term volume outlook outweighed the improved profit guidance.
Seed segment sales were essentially flat at $4.53 billion in the quarter, with a 3% increase in price/mix offsetting a 3% volume decline. Seed operating EBITDA rose 6% to $1.97 billion, with margin expanding more than 230 basis points on higher technology adoption and improved royalty economics. Crop Protection sales declined 4% to $1.85 billion on a 4% pricing decline and 2% volume drop, though operating EBITDA still rose 2% to $342 million on cost savings and favorable currency effects.
Corteva lifted its full-year 2026 outlook to operating EBITDA of $4.1 billion to $4.3 billion and operating EPS of $3.60 to $3.80, implying roughly 9% EBITDA growth and 11% EPS growth at the midpoint. First-half net sales rose 4% to $11.3 billion, with operating EBITDA up 10% to $3.7 billion and margins expanding nearly 200 basis points to about 32.8%.
New crop protection products are expected to generate around $2 billion of revenue this year, with volumes growing at a high single-digit rate in the first half. Licensing net royalties added about $90 million, and cost and productivity gains contributed more than $160 million to first-half EBITDA. The planned separation into two companies remains on track for the fourth quarter, with timing-related dis-synergies now estimated at only about $25 million.
Crop Protection pricing remains under pressure, particularly in Latin America. Management expects second-half pricing in the segment to decline in the low- to mid-single digits, with no meaningful price recovery expected in Brazil in 2026 for certain pre-emergent herbicides facing generic competition. Organic crop protection sales are down roughly 6% year-to-date.
The company is guiding to a highly seasonal second half with a planned operating EBITDA loss of about $100 million in the third quarter, with most remaining earnings expected in the fourth quarter. Operating cash flow was down by a couple of billion dollars in the first half, weighed by a $1.1 billion pension contribution, a major agreement with another company and separation-related spending.
Tight farmer margins in Latin America, driven by higher interest rates, fuel and fertilizer costs, are causing growers to delay purchases. In Brazil, tighter credit conditions add to uncertainty for second-half seed and crop protection sales.
The raised guidance assumes low-single-digit organic growth in seed and high-single-digit volume gains in crop protection, with management targeting an operating EBITDA margin of 22.5% to 23.5%. The stock trades at 19.61 times forward 12-month earnings, above the Zacks sub-industry average of 13.99 times.
The guidance raise shows management expects technology adoption and productivity gains to offset persistent pricing headwinds. Investors will watch the planned separation and fourth-quarter earnings for evidence that the crop protection segment can stabilize pricing in Brazil.
This article is for informational purposes only and does not constitute investment advice.
